Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3090.0
(0.16%)
JPY 3090.0
(0.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 102.88 Billion JPY | -0.36% |
| 2022 | 103.26 Billion JPY | -6.28% |
| 2021 | 110.17 Billion JPY | 6.98% |
| 2020 | 102.99 Billion JPY | 1.17% |
| 2019 | 101.8 Billion JPY | -7.16% |
| 2018 | 109.65 Billion JPY | 2.72% |
| 2017 | 106.74 Billion JPY | 9.65% |
| 2016 | 97.35 Billion JPY | 5.5% |
| 2015 | 92.27 Billion JPY | 5.74% |
| 2014 | 87.26 Billion JPY | -7.12% |
| 2013 | 93.95 Billion JPY | 5.29% |
| 2012 | 89.23 Billion JPY | 3.52% |
| 2011 | 86.19 Billion JPY | 8.66% |
| 2010 | 79.32 Billion JPY | 0.99% |
| 2009 | 78.54 Billion JPY | 4.5% |
| 2008 | 75.16 Billion JPY | 0.77% |
| 2007 | 74.59 Billion JPY | 0.71% |
| 2006 | 74.07 Billion JPY | 4.86% |
| 2005 | 70.64 Billion JPY | 3.84% |
| 2004 | 68.02 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 25.4 Billion JPY | 3.0% |
| 2024 Q2 | 25.68 Billion JPY | 1.11% |
| 2023 FY | 102.88 Billion JPY | -0.36% |
| 2023 Q4 | 24.66 Billion JPY | -14.18% |
| 2023 Q3 | 28.74 Billion JPY | 16.23% |
| 2023 Q1 | 24.74 Billion JPY | 13.17% |
| 2023 Q2 | 24.72 Billion JPY | -0.07% |
| 2022 Q1 | 27.69 Billion JPY | 9.17% |
| 2022 Q4 | 21.86 Billion JPY | -22.44% |
| 2022 Q3 | 28.19 Billion JPY | 10.53% |
| 2022 Q2 | 25.5 Billion JPY | -7.89% |
| 2022 FY | 103.26 Billion JPY | -6.28% |
| 2021 Q4 | 25.36 Billion JPY | -17.66% |
| 2021 Q1 | 27.36 Billion JPY | 18.34% |
| 2021 FY | 110.17 Billion JPY | 6.98% |
| 2021 Q2 | 26.64 Billion JPY | -2.61% |
| 2021 Q3 | 30.8 Billion JPY | 15.6% |
| 2020 Q2 | 24.24 Billion JPY | -11.44% |
| 2020 FY | 102.99 Billion JPY | 1.17% |
| 2020 Q1 | 27.37 Billion JPY | 20.54% |
| 2020 Q4 | 23.12 Billion JPY | -18.15% |
| 2020 Q3 | 28.25 Billion JPY | 16.52% |
| 2019 Q2 | 25.02 Billion JPY | -5.53% |
| 2019 Q1 | 26.48 Billion JPY | 20.27% |
| 2019 FY | 101.8 Billion JPY | -7.16% |
| 2019 Q4 | 22.71 Billion JPY | -17.66% |
| 2019 Q3 | 27.58 Billion JPY | 10.24% |
| 2018 FY | 109.65 Billion JPY | 2.72% |
| 2018 Q2 | 27.43 Billion JPY | -7.93% |
| 2018 Q3 | 30.39 Billion JPY | 10.8% |
| 2018 Q4 | 22.02 Billion JPY | -27.55% |
| 2018 Q1 | 29.79 Billion JPY | 29.37% |
| 2017 Q4 | 23.03 Billion JPY | -20.92% |
| 2017 Q3 | 29.12 Billion JPY | 13.88% |
| 2017 Q1 | 29.01 Billion JPY | 19.32% |
| 2017 FY | 106.74 Billion JPY | 9.65% |
| 2017 Q2 | 25.57 Billion JPY | -11.84% |
| 2016 Q2 | 21.91 Billion JPY | -10.6% |
| 2016 Q4 | 24.31 Billion JPY | -8.61% |
| 2016 Q3 | 26.6 Billion JPY | 21.38% |
| 2016 FY | 97.35 Billion JPY | 5.5% |
| 2016 Q1 | 24.51 Billion JPY | 21.88% |
| 2015 FY | 92.27 Billion JPY | 5.74% |
| 2015 Q4 | 20.11 Billion JPY | -24.93% |
| 2015 Q3 | 26.79 Billion JPY | 17.97% |
| 2015 Q2 | 22.71 Billion JPY | 0.32% |
| 2015 Q1 | 22.64 Billion JPY | 13.36% |
| 2014 Q2 | 21.98 Billion JPY | 7.56% |
| 2014 Q3 | 24.86 Billion JPY | 13.1% |
| 2014 Q4 | 19.97 Billion JPY | -19.66% |
| 2014 FY | 87.26 Billion JPY | -7.12% |
| 2014 Q1 | 20.43 Billion JPY | -8.16% |
| 2013 Q1 | 22.36 Billion JPY | 8.61% |
| 2013 Q3 | 26.36 Billion JPY | 14.8% |
| 2013 Q4 | 22.25 Billion JPY | -15.59% |
| 2013 FY | 93.95 Billion JPY | 5.29% |
| 2013 Q2 | 22.96 Billion JPY | 2.69% |
| 2012 FY | 89.23 Billion JPY | 3.52% |
| 2012 Q3 | 25 Billion JPY | 12.19% |
| 2012 Q4 | 20.59 Billion JPY | -17.64% |
| 2012 Q1 | 21.35 Billion JPY | 16.49% |
| 2012 Q2 | 22.28 Billion JPY | 4.37% |
| 2011 Q1 | 19.03 Billion JPY | 1.6% |
| 2011 Q2 | 23.48 Billion JPY | 23.4% |
| 2011 Q4 | 18.33 Billion JPY | -27.69% |
| 2011 FY | 86.19 Billion JPY | 8.66% |
| 2011 Q3 | 25.34 Billion JPY | 7.94% |
| 2010 Q2 | 19.5 Billion JPY | -0.05% |
| 2010 Q1 | 19.51 Billion JPY | 15.14% |
| 2010 Q3 | 21.56 Billion JPY | 10.55% |
| 2010 Q4 | 18.73 Billion JPY | -13.15% |
| 2010 FY | 79.32 Billion JPY | 0.99% |
| 2009 Q2 | 19.8 Billion JPY | 1.91% |
| 2009 Q4 | 16.95 Billion JPY | -24.15% |
| 2009 Q3 | 22.34 Billion JPY | 12.82% |
| 2009 Q1 | 19.43 Billion JPY | 14.46% |
| 2009 FY | 78.54 Billion JPY | 4.5% |
| 2008 Q4 | 16.98 Billion JPY | -18.76% |
| 2008 Q2 | 18.63 Billion JPY | 0.0% |
| 2008 FY | 75.16 Billion JPY | 0.77% |
| 2008 Q3 | 20.9 Billion JPY | 12.16% |
| 2007 FY | 74.59 Billion JPY | 0.71% |
| 2006 FY | 74.07 Billion JPY | 4.86% |
| 2005 FY | 70.64 Billion JPY | 3.84% |
| 2004 FY | 68.02 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -65.551% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 97.587% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 67.292% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 76.353% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -1229.534% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 30.603% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -42.809% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 86.129% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -729.316% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 27.395% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -85.693% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -234.607% |
| Tsumura & Co. | 150.84 Billion JPY | 31.794% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -36.129% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -88.303% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 54.862% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -151.62% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -35.866% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 13.927% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -1941.369% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -119.394% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -1740.615% |
| MedRx Co., Ltd | 26 Million JPY | -395611.538% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -836.192% |
| Solasia Pharma K.K. | 617 Million JPY | -16575.041% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -63.718% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 41.828% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -168254.824% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 93.033% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -364.825% |